home / stock / bwv / bwv news


BWV News and Press, Blue Water Vaccines Inc. From 11/10/22

Stock Information

Company Name: Blue Water Vaccines Inc.
Stock Symbol: BWV
Market: NASDAQ

Menu

BWV BWV Quote BWV Short BWV News BWV Articles BWV Message Board
Get BWV Alerts

News, Short Squeeze, Breakout and More Instantly...

BWV - Blue Water Vaccines GAAP EPS of -$0.27

Blue Water Vaccines press release ( NASDAQ: BWV ): Q3 GAAP EPS of -$0.27. Cash was $29.1 million as of September 30, 2022, as compared to $1.9 million as of December 31, 2021. For further details see: Blue Water Vaccines GAAP EPS of -$0.27

BWV - Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program

Closed private placement in August 2022, with net proceeds of approximately $8.7 million Announced plans to evaluate efficacy of BWV-201 for protection against non-invasive pneumococcal pneumonia in children and adults Board of Directors authorized a 5 million share repurchase p...

BWV - Blue Water Vaccines Announces Appointment of Vuk Jeremi?, Previous Chair of the Council of Europe's Committee of Ministers and Previous President of the United Nations General Assembly, to Its Board of Directors

CINCINNATI, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

BWV - October 2022 Equity Market Outlook: Market Volatility Expected To Persist

Summary With inflationary pressures and recessionary fears remaining top-of-mind, equity managers see no short-term end to the bumpy ride in markets. One of the key risks cited by equity managers in our third-quarter report is the possibility of inflation remaining stuck at high l...

BWV - Blue Water plans to evaluate BWV-201 vaccine for pneumococcal pneumonia

Blue Water Vaccines ( NASDAQ: BWV ) said it plans to evaluate BWV-201, its Streptococcus pneumoniae ((SP) vaccine candidate to prevent acute otitis media (AOM), to also protect against non-invasive pneumococcal pneumonia. Otitis media is inflammation in ...

BWV - Blue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in Barcelona

CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

BWV - Blue Water Vaccines to Present at World Vaccine Congress Europe 2022

CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announ...

BWV - Week Ahead - All About Inflation, BOE Decision Pushed Back, Xi To Meet Putin

Summary The main economic data release for the trading week is the US inflation report. The UK economy is in a precarious position and facing a recession. Chinese President Xi is expected to meet with Russian President Putin at the Shanghai Cooperation Organisation summit in U...

BWV - Blue Water Vaccines to Present In Person and via Webcast at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

CINCINNATI, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

BWV - Blue Water Vaccines to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

CINCINNATI, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announce...

Previous 10 Next 10